Evidence map›Paper›PMID 35295081›Full record

Trial reportHaematologica2022

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.

Cathelijne Fokkema, Phillipe Moreau, Bronno Van der Holt, Jérôme Lambert, Mark Van Duin, Ruth Wester, Joost L M Jongen, Pieter A Van Doorn, Sophie Godet, Kon Siong Jie and 10 more

Abstract readClinical Trial, Phase III
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Cathelijne FokkemaDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Phillipe MoreauHematology Department, University Hospital Hôtel-Dieu, Nantes.
Bronno Van der HoltHOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Jérôme LambertBiostatistical Department, Hospital Saint Louis, Paris.
Mark Van DuinDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Ruth WesterDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Joost L M JongenDepartment of Neurology, Erasmus MC, Rotterdam.
Pieter A Van DoornDepartment of Neurology, Erasmus MC, Rotterdam.
Sophie GodetDepartment of Hematology, University Hospital of Reims and UFR Médicine, Reims.
Kon Siong JieDepartment of Hematology, Zuyderland MC, Sittard.
Olivier FitoussiDepartment of Hematology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux.
Michel DelforgeDepartment of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Awa Keita-MantaPremier Research, CRO, Paris.
Odile LuycxDepartment of Hematology, Hospital Scorff Hospital Group Bretagne Sud, Lorient.
Tom CupedoDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Niels W C J Van de DonkDepartment of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam.
Sonja ZweegmanDepartment of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam.
Jessica T VermeulenJanssen Research and Development, LLC, Leiden.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Annemiek BroijlDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam. a.broyl@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Peripheral Nervous System DiseasesAgedBortezomibFemaleHumansMaleMiddle AgedBortezomib

Identifiers

PMID35295081
PMCPMC9244836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.